Catheter Precision (VTAK) — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Total funding raised: $25M

Market Cap: $2.4MFounded: 2013HQ: Fort Mill, United States

Sector Ranking#101 in Digital Health & Biotech SaaS

Overview

Catheter Precision Inc. is a public medical device company with a mission to empower electrophysiologists through innovative tools that enhance procedural planning and execution. Its strategic pivot from robotics to a portfolio of complementary EP devices, anchored by the VIVO™ pre-procedural mapping system, positions it to address key workflow inefficiencies. The company aims to improve patient outcomes while building hospital relationships through its expanding product suite, though it faces the challenges of commercial execution in a competitive market.

CardiovascularCardiac Arrhythmias

Technology Platform

Portfolio of complementary medical devices for electrophysiology procedures, centered on the non-invasive VIVO™ 3D imaging/mapping software and the LockeT vascular closure device.

Funding History

2

Total raised:$25M

Series B$15MUndisclosedSep 15, 2022

Series A$10MUndisclosedJun 15, 2021

Opportunities

The growing global EP market, particularly complex VT ablation, presents a need for tools that improve procedural efficiency and outcomes.

Catheter Precision's focused portfolio addresses specific workflow pain points, and the LockeT device provides a strategic entry point for broader account penetration.

Risk Factors

Key risks include commercial execution challenges against larger competitors, limited financial resources for scaling, technological obsolescence, the need for robust clinical validation to drive adoption, and the inherent volatility of being a micro-cap OTC-listed stock.

Competitive Landscape

Faces competition from large EP players (J&J, Abbott, Medtronic) in adjacent spaces. VIVO™ competes with non-invasive mapping tech like ECGI, while LockeT enters a crowded vascular closure market. The company's strategy is niche focus and complementarity rather than direct displacement.